Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Look to tap potential...

    Look to tap potential of mega healthcare scheme: Philips

    Written by Ruby Khatun Khatun Published On 2018-02-12T10:15:18+05:30  |  Updated On 12 Feb 2018 10:15 AM IST
    Look to tap potential of mega healthcare scheme: Philips

    New Delhi: Philips India is keen to tap the opportunities arising out of the mega healthcare scheme announced in the Budget, especially in the public-private partnership (PPP) space.


    The company has the presence in the fields of diagnostic imaging, image-guided therapy, patient monitoring and health informatics.


    Philips India, a subsidiary of Royal Philips of the Netherlands, is also present in segments like consumer electronics and personal care and aims to continue its double-digit growth in 2018.


    "The government sent a very clear signal with this budget that healthcare is a priority and we will continue work with them and we will continue to push PPPs. We will be leaders of PPPs in the country," the company's Vice Chairman and Managing Director for the Indian Subcontinent, Daniel Mazon told PTI.


    The National Health Protection Scheme, which would be the world's largest government healthcare programme, was announced in 2018-19 Budget for providing medical cover of up to Rs 500000 to over 100 million poor and vulnerable families, constituting 40 percent of India's total population.


    Presently, Philips India is operating 36 PPPs in different tier II and III cities.


    "It's about making choices, focus on particular areas. One of them is PPPs and you will continue seeing Philips dominating that space. We love PPPs. PPP is a great way to create access, to lower cost, to bring healthcare to tier II and III cities in the country," he added.


    "Philips has been in India for 88 years and the company is in the journey of a transformational double-digit growth, " said Mazon.


    "There are so many opportunities in this country and Philips has amazing talent, a lot of patents and invests heavily in R&D and manufacturing and we tap into everything we do. That's how we impact the lives of so many people," he added.


    The company is also encouraging local manufacturing under the 'Make-in-India' initiative.


    Its Pune-based center is becoming a manufacturing hub for Philips globally.

    Budgetbudget 2018Daniel Mazondiagnostic imaginghealth Budgethealth informaticsHealthcareImage Guided Therapymega healthcare schemeNational Health Protection SchemePhilipsPhilips Indiapublic private partnershipRoyal Philips
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok